Pediatric Drug therapy in the emergency department : Does it meet FDA-approved prescribing guidelines ?
Society for Academic Emergency Medecine Annual Meeting. San Antonio, TX (USA), 1995/05.
To determine how often Food and Drug Administration (FDA) - approved age-specific prescribing guidelines were followed in pediatric emergency department (ED) patients, the charts for all children presenting to a university hospital pediatric ED during a 30-day period were reviewed.
Of the 359 children who received drug therapy in the ED, 43% received one or more drugs not approved for use at the patients'respective ages.
Of 296 children discharged with one or more prescriptions, 16% received a drug prescribed outside of FDA-approved guidelines based on age criteria.
Overall, 34% of children who received drug therapy in the ED or by prescription did not meet age-specific FDA-approved prescribing guidelines.
The medications most commonly given outside FDA-approved guidelines were bronchodilators, benzodiazepines, and narcotic analgesics.
Drug therapy in pediatric ED patients often falls outside FDA-approved prescribing guidelines.
Mots-clés Pascal : Prescription médicale, Médicament, Service hospitalier, Urgence, Pédiatrie, Recommandation, Age, Evaluation, Enfant, Homme, Etats Unis, Amérique du Nord, Amérique, Soin intensif, Service urgence
Mots-clés Pascal anglais : Medical prescription, Drug, Hospital ward, Emergency, Pediatrics, Recommendation, Age, Evaluation, Child, Human, United States, North America, America, Intensive care, Emergency departement
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0290090
Code Inist : 002B02A07. Création : 15/07/1997.